Skip to main content
Erschienen in: European Journal of Pediatrics 3/2011

01.03.2011 | Review

Educational paper

Screening in cancer predisposition syndromes: guidelines for the general pediatrician

verfasst von: Alexis Teplick, Megan Kowalski, Jaclyn A. Biegel, Kim E. Nichols

Erschienen in: European Journal of Pediatrics | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Improvements in our understanding of the genetic basis of human disease and increased utilization of genetic testing have identified a variety of heritable disorders associated with the onset of benign or malignant neoplasms during childhood. In many cases, the optimal management of affected children is dependent upon the early detection and treatment of tumors. Surveillance strategies based on the natural history of these lesions are often complex, requiring clinical examinations and radiologic and laboratory studies that evolve over a patient’s lifetime. A general pediatrician may be the first to suspect one of these disorders in a patient, or may be faced with questions regarding genetic testing, cancer risk, and cancer screening. The pediatrician may also coordinate and interpret the results of specific surveillance studies. In this review, we present the genetic etiology, presentation, natural history, and surveillance recommendations for four disparate hereditary tumor predisposing syndromes, including Beckwith–Wiedemann syndrome/idiopathic hemihyperplasia, von Hippel–Lindau disease, Li–Fraumeni syndrome, and rhabdoid tumor/schwannomatosis. These examples are meant to offer the clinician practical recommendations as well as a framework upon which to base the understanding and management of other conditions associated with an increased risk to develop tumors in childhood.
Literatur
1.
Zurück zum Zitat Baghai M, Thompson GB, Young WF Jr et al (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682–688PubMedCrossRef Baghai M, Thompson GB, Young WF Jr et al (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682–688PubMedCrossRef
2.
Zurück zum Zitat Baldisserotto M, Peletti AB, Angelo de Araújo M et al (2005) Beckwith-Wiedemann syndrome and bilateral adrenal pheochromocytoma: sonography and MRI findings. Pediatr Radiol 35:1132–1134PubMedCrossRef Baldisserotto M, Peletti AB, Angelo de Araújo M et al (2005) Beckwith-Wiedemann syndrome and bilateral adrenal pheochromocytoma: sonography and MRI findings. Pediatr Radiol 35:1132–1134PubMedCrossRef
3.
Zurück zum Zitat Barlaskar FM, Hammer GD (2007) The molecular genetics of adrenocortical carcinoma. Rev Endocr Metab Disord 8:343–348PubMedCrossRef Barlaskar FM, Hammer GD (2007) The molecular genetics of adrenocortical carcinoma. Rev Endocr Metab Disord 8:343–348PubMedCrossRef
4.
Zurück zum Zitat Beckwith JB (1998) Children at increased risk for Wilms tumor: monitoring issues. J Pediatr 132:377–379PubMedCrossRef Beckwith JB (1998) Children at increased risk for Wilms tumor: monitoring issues. J Pediatr 132:377–379PubMedCrossRef
5.
Zurück zum Zitat Bémurat L, Gosse P, Ballanger P et al (2002) Successful lapaproscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome. J Hum Hypertens 16:281–284PubMedCrossRef Bémurat L, Gosse P, Ballanger P et al (2002) Successful lapaproscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome. J Hum Hypertens 16:281–284PubMedCrossRef
6.
Zurück zum Zitat Bliek J, Gicquel C, Maas S et al (2004) Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 145:796–799PubMedCrossRef Bliek J, Gicquel C, Maas S et al (2004) Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 145:796–799PubMedCrossRef
7.
Zurück zum Zitat Biegel JA, Zhou J, Rorke LB et al (1999) Germ-line and acquired mutations of INI1 in atypical teratoid rhabdoid tumor. Cancer Res 59:74–79PubMed Biegel JA, Zhou J, Rorke LB et al (1999) Germ-line and acquired mutations of INI1 in atypical teratoid rhabdoid tumor. Cancer Res 59:74–79PubMed
8.
Zurück zum Zitat Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li–Fraumeni families. Cancer Res 54:1298–1304PubMed Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li–Fraumeni families. Cancer Res 54:1298–1304PubMed
9.
Zurück zum Zitat Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628PubMedCrossRef Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628PubMedCrossRef
10.
Zurück zum Zitat Boyd C, Smith MJ, Kluwe L et al (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358–366PubMedCrossRef Boyd C, Smith MJ, Kluwe L et al (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358–366PubMedCrossRef
11.
Zurück zum Zitat Bruggers CS, Bleyl SB, Pysher T et al (2010) Clincopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer. doi:10.1002/pbc.22757 PubMed Bruggers CS, Bleyl SB, Pysher T et al (2010) Clincopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer. doi:10.​1002/​pbc.​22757 PubMed
12.
Zurück zum Zitat Burgess J (2010) How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol Oxf 72:13–16PubMedCrossRef Burgess J (2010) How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol Oxf 72:13–16PubMedCrossRef
13.
Zurück zum Zitat Choyke PL, Siegel MJ, Craft AW et al (1999) Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32:196–200PubMedCrossRef Choyke PL, Siegel MJ, Craft AW et al (1999) Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32:196–200PubMedCrossRef
14.
Zurück zum Zitat Clericuzio CL, Chen E, McNeil DE et al (2003) Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 143:270–272PubMedCrossRef Clericuzio CL, Chen E, McNeil DE et al (2003) Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 143:270–272PubMedCrossRef
15.
Zurück zum Zitat Clark PE, Cookson MS (2008) The von Hippel-Lindau gene: turning discovery into therapy. Cancer 113:1768–1778PubMedCrossRef Clark PE, Cookson MS (2008) The von Hippel-Lindau gene: turning discovery into therapy. Cancer 113:1768–1778PubMedCrossRef
16.
Zurück zum Zitat Coleman JA (2008) Familial and hereditary renal cancer syndromes. Urol Clin North Am 35:563–572PubMedCrossRef Coleman JA (2008) Familial and hereditary renal cancer syndromes. Urol Clin North Am 35:563–572PubMedCrossRef
17.
Zurück zum Zitat Cooper WN, Luharia A, Evans GA et al (2005) Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13:1025–1032PubMedCrossRef Cooper WN, Luharia A, Evans GA et al (2005) Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13:1025–1032PubMedCrossRef
18.
Zurück zum Zitat Eaton KW, Tooke LS, Wainwright LM et al (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56(1):7–15PubMedCrossRef Eaton KW, Tooke LS, Wainwright LM et al (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56(1):7–15PubMedCrossRef
19.
Zurück zum Zitat Engel JR, Smallwood A, Harper A et al (2000) Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 37:921–926PubMedCrossRef Engel JR, Smallwood A, Harper A et al (2000) Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 37:921–926PubMedCrossRef
20.
Zurück zum Zitat Evans DG, Lunt P, Clancy T, Eeles R (2010) Childhood predictive genetic testing for Li–Fraumeni syndrome. Fam Cancer 9:65–69PubMedCrossRef Evans DG, Lunt P, Clancy T, Eeles R (2010) Childhood predictive genetic testing for Li–Fraumeni syndrome. Fam Cancer 9:65–69PubMedCrossRef
21.
Zurück zum Zitat Everman DB, Shuman C, Dzolganovski B et al (2000) Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 137:123–127PubMedCrossRef Everman DB, Shuman C, Dzolganovski B et al (2000) Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 137:123–127PubMedCrossRef
23.
Zurück zum Zitat Field M, Shanley S, Kirk J (2007) Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health 43:219–229PubMedCrossRef Field M, Shanley S, Kirk J (2007) Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health 43:219–229PubMedCrossRef
24.
Zurück zum Zitat Hilden JM, Meerbaum S, Burger P et al (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22:2877–2884PubMedCrossRef Hilden JM, Meerbaum S, Burger P et al (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22:2877–2884PubMedCrossRef
25.
Zurück zum Zitat Hisada M, Garber JE, Fung CY et al (1998) Multiple primary cancers in families with Li–Fraumeni syndrome. J Natl Cancer Inst 90:606–611PubMedCrossRef Hisada M, Garber JE, Fung CY et al (1998) Multiple primary cancers in families with Li–Fraumeni syndrome. J Natl Cancer Inst 90:606–611PubMedCrossRef
26.
Zurück zum Zitat Hoyme HE, Seaver LH, Jones KL et al (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274–278PubMedCrossRef Hoyme HE, Seaver LH, Jones KL et al (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274–278PubMedCrossRef
27.
Zurück zum Zitat Hulsebos TJM, Plomp AS, Woterman RA et al (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805–810PubMedCrossRef Hulsebos TJM, Plomp AS, Woterman RA et al (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805–810PubMedCrossRef
28.
Zurück zum Zitat Hwang SJ, Lozano G, Amos CI, Strong LC (2003) Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 72:975–983PubMedCrossRef Hwang SJ, Lozano G, Amos CI, Strong LC (2003) Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 72:975–983PubMedCrossRef
29.
Zurück zum Zitat Jackson EM, Shaikh TH, Zhang F et al (2007) Atypical teratoid/rhabdoid tumor in a patient with Beckwith-Wiedemann syndrome. Am J Med Genet A 143A:1767–1770PubMedCrossRef Jackson EM, Shaikh TH, Zhang F et al (2007) Atypical teratoid/rhabdoid tumor in a patient with Beckwith-Wiedemann syndrome. Am J Med Genet A 143A:1767–1770PubMedCrossRef
30.
Zurück zum Zitat Kaatsch P, Steliarova-Foucher E, Crocetti E et al (2006) Time trends of cancer incidence in European children (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer 42:1961–1971PubMedCrossRef Kaatsch P, Steliarova-Foucher E, Crocetti E et al (2006) Time trends of cancer incidence in European children (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer 42:1961–1971PubMedCrossRef
31.
Zurück zum Zitat Katzenstein HM, London WB, Douglass E et al (2002) Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. J Clin Oncol 20:3438–3444PubMedCrossRef Katzenstein HM, London WB, Douglass E et al (2002) Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. J Clin Oncol 20:3438–3444PubMedCrossRef
32.
Zurück zum Zitat Kim HJ, Butman JA, Brewer C et al (2005) Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis and treatment. J Neurosurg 102:503–512PubMedCrossRef Kim HJ, Butman JA, Brewer C et al (2005) Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis and treatment. J Neurosurg 102:503–512PubMedCrossRef
33.
Zurück zum Zitat Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet 137C:53–71PubMedCrossRef Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet 137C:53–71PubMedCrossRef
34.
Zurück zum Zitat Lammens CRM, Aaronson NK, Wagner A et al (2010) Genetic testing in Li–Fraumeni Syndrome: uptake and psychosocial consequences. J Clin Oncol 28:3008–3014PubMedCrossRef Lammens CRM, Aaronson NK, Wagner A et al (2010) Genetic testing in Li–Fraumeni Syndrome: uptake and psychosocial consequences. J Clin Oncol 28:3008–3014PubMedCrossRef
35.
Zurück zum Zitat Lammens CRM, Bleiker EMA, Aaronson NK et al (2010) Regular surveillance for Li–Fraumeni syndrome: advice, adherence and perceived benefits. Fam Cancer 9(4):647–654PubMedCrossRef Lammens CRM, Bleiker EMA, Aaronson NK et al (2010) Regular surveillance for Li–Fraumeni syndrome: advice, adherence and perceived benefits. Fam Cancer 9(4):647–654PubMedCrossRef
36.
Zurück zum Zitat Li FP, Fraumeni JF (1982) Prospective study of a family cancer syndrome. JAMA 247:2692–2694PubMedCrossRef Li FP, Fraumeni JF (1982) Prospective study of a family cancer syndrome. JAMA 247:2692–2694PubMedCrossRef
37.
Zurück zum Zitat Lonser RR, Glenn GM, Walther M et al (2003) von Hippel-Lindau disease. Lancet 361:2059–2067PubMedCrossRef Lonser RR, Glenn GM, Walther M et al (2003) von Hippel-Lindau disease. Lancet 361:2059–2067PubMedCrossRef
38.
Zurück zum Zitat MacCollin M, Chiocca EA, Evans DG et al (2005) Diagnostic criteria for schwannomatosis. Neurology 64:1838–1845PubMedCrossRef MacCollin M, Chiocca EA, Evans DG et al (2005) Diagnostic criteria for schwannomatosis. Neurology 64:1838–1845PubMedCrossRef
39.
Zurück zum Zitat Maher ER, Yates JR, Harries R et al (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–1163PubMed Maher ER, Yates JR, Harries R et al (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–1163PubMed
40.
Zurück zum Zitat Manksi TJ, Heffner DK, Glenn GM et al (1997) Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461–1466CrossRef Manksi TJ, Heffner DK, Glenn GM et al (1997) Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461–1466CrossRef
41.
Zurück zum Zitat Masciari S, Van den Abbeele AD, Diller LR (2008) F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li–Fraumeni syndrome. JAMA 299:1315–1319PubMedCrossRef Masciari S, Van den Abbeele AD, Diller LR (2008) F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li–Fraumeni syndrome. JAMA 299:1315–1319PubMedCrossRef
42.
Zurück zum Zitat Meister M, Choyke P, Anderson C, Patel U (2009) Radiological evaluation, management and surveillance of renal masses in Von Hippel-Lindau disease. Clin Radiol 64:589–600PubMedCrossRef Meister M, Choyke P, Anderson C, Patel U (2009) Radiological evaluation, management and surveillance of renal masses in Von Hippel-Lindau disease. Clin Radiol 64:589–600PubMedCrossRef
43.
Zurück zum Zitat Moule RN, Jhavar SG, Eeles RA (2006) Genotype phenotype correlation in Li–Fraumeni syndrome kindreds and its implications for management. Fam Cancer 5:129–133PubMedCrossRef Moule RN, Jhavar SG, Eeles RA (2006) Genotype phenotype correlation in Li–Fraumeni syndrome kindreds and its implications for management. Fam Cancer 5:129–133PubMedCrossRef
44.
Zurück zum Zitat NCCN (2008) The NCCN Clinical Practice Guidelines in Oncology™ Li–Fraumeni syndrome (Version 1.2008). © 2009 National Comprehensive Cancer Network, Inc. www.nccn.org. Accessed March 15, 2009. To view the most recent and complete version of the NCCN Guidelines, login to http://www.nccn.org NCCN (2008) The NCCN Clinical Practice Guidelines in Oncology™ Li–Fraumeni syndrome (Version 1.2008). © 2009 National Comprehensive Cancer Network, Inc. www.​nccn.​org. Accessed March 15, 2009. To view the most recent and complete version of the NCCN Guidelines, login to http://​www.​nccn.​org
45.
Zurück zum Zitat Neumann HP, Bender BU, Berger DP et al (1998) Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160:1248–1254PubMedCrossRef Neumann HP, Bender BU, Berger DP et al (1998) Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160:1248–1254PubMedCrossRef
46.
Zurück zum Zitat Oda Y, Tsuneyoshi M (2006) Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 56:287–295PubMedCrossRef Oda Y, Tsuneyoshi M (2006) Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 56:287–295PubMedCrossRef
47.
Zurück zum Zitat Olivier M, Goldgar DE, Sodha N et al (2003) Li–Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643–6650PubMed Olivier M, Goldgar DE, Sodha N et al (2003) Li–Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643–6650PubMed
48.
Zurück zum Zitat Perilongo G, Shafford E, Maibach R (2004) Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2. Eur J Cancer 40:411–421PubMedCrossRef Perilongo G, Shafford E, Maibach R (2004) Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2. Eur J Cancer 40:411–421PubMedCrossRef
49.
Zurück zum Zitat Poulsen MLM, Budtz-Jørgensen E, Bisgaard ML (2010) Surveillance in von Hippel-Lindau disease (vHL). Clin Genet 77:49–59PubMedCrossRef Poulsen MLM, Budtz-Jørgensen E, Bisgaard ML (2010) Surveillance in von Hippel-Lindau disease (vHL). Clin Genet 77:49–59PubMedCrossRef
50.
Zurück zum Zitat Porteus MH, Narkool P, Neuberg D et al (2000) Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the national Wilms tumor study group. J Clin Oncol 18:2026–2031PubMed Porteus MH, Narkool P, Neuberg D et al (2000) Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the national Wilms tumor study group. J Clin Oncol 18:2026–2031PubMed
51.
Zurück zum Zitat Priesemann M, Davies KM, Perry LA et al (2006) Benefits of screening in von Hippel-Lindau disease—comparison of morbidity associated with initial tumours in affected parents and children. Horm Res 66:1–5PubMedCrossRef Priesemann M, Davies KM, Perry LA et al (2006) Benefits of screening in von Hippel-Lindau disease—comparison of morbidity associated with initial tumours in affected parents and children. Horm Res 66:1–5PubMedCrossRef
52.
Zurück zum Zitat Proust F, Laquerriere A, Constantin B et al (1999) Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J Neuroncol 43:63–70CrossRef Proust F, Laquerriere A, Constantin B et al (1999) Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J Neuroncol 43:63–70CrossRef
53.
Zurück zum Zitat Rao A, Rothman J, Nichols KE (2008) Genetic testing and tumor surveillance for children with cancer predisposition syndromes. Curr Opin Pediatr 20:1–7PubMedCrossRef Rao A, Rothman J, Nichols KE (2008) Genetic testing and tumor surveillance for children with cancer predisposition syndromes. Curr Opin Pediatr 20:1–7PubMedCrossRef
54.
Zurück zum Zitat Reisman D, Glaros S, Thompson EA (2009) The SWI/SNF complex and cancer. Oncogene 28:1653–1668PubMedCrossRef Reisman D, Glaros S, Thompson EA (2009) The SWI/SNF complex and cancer. Oncogene 28:1653–1668PubMedCrossRef
55.
Zurück zum Zitat Ries LAG, Smith MA, Gurney JG et al. editors (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda (MD): National Cancer Institute, SEER Program NIH Pub. No. 99–4649 Ries LAG, Smith MA, Gurney JG et al. editors (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda (MD): National Cancer Institute, SEER Program NIH Pub. No. 99–4649
56.
Zurück zum Zitat Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedCrossRef Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedCrossRef
58.
Zurück zum Zitat Sévenet N, Sheridan E, Amram D et al (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancer. Am J Hum Genet 65:1342–1348PubMedCrossRef Sévenet N, Sheridan E, Amram D et al (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancer. Am J Hum Genet 65:1342–1348PubMedCrossRef
59.
Zurück zum Zitat Slavin TP, Wiesner GL (2009) Developmental defects and childhood cancer. Curr Opin Pediatr 21:717–723PubMedCrossRef Slavin TP, Wiesner GL (2009) Developmental defects and childhood cancer. Curr Opin Pediatr 21:717–723PubMedCrossRef
60.
Zurück zum Zitat Strahm B, Malkin D (2006) Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 119:2001–2006PubMedCrossRef Strahm B, Malkin D (2006) Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 119:2001–2006PubMedCrossRef
61.
Zurück zum Zitat Swensen JJ, Keyser J, Coffin CM et al (2009) Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 46:68–72PubMedCrossRef Swensen JJ, Keyser J, Coffin CM et al (2009) Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 46:68–72PubMedCrossRef
62.
Zurück zum Zitat Tabori U, Malkin D (2008) Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li–Fraumeni syndrome. Cancer Res 68:2053–2057PubMedCrossRef Tabori U, Malkin D (2008) Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li–Fraumeni syndrome. Cancer Res 68:2053–2057PubMedCrossRef
63.
Zurück zum Zitat Tan TY, Amor DJ (2006) Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 42:486–490PubMedCrossRef Tan TY, Amor DJ (2006) Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 42:486–490PubMedCrossRef
64.
Zurück zum Zitat Tomlinson GE, Breslow NE, Dome J et al (2005) Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol 23:7641–7645PubMedCrossRef Tomlinson GE, Breslow NE, Dome J et al (2005) Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol 23:7641–7645PubMedCrossRef
65.
66.
Zurück zum Zitat Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413–431PubMedCrossRef Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413–431PubMedCrossRef
67.
Zurück zum Zitat Weksberg R, Nishikawa J, Caluseriu O et al (2001) Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 10:2989–3000PubMedCrossRef Weksberg R, Nishikawa J, Caluseriu O et al (2001) Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 10:2989–3000PubMedCrossRef
68.
Zurück zum Zitat Weksberg R, Shuman C, Smith A (2005) Beckwith-Wiedemann syndrome. Am J Med Genet 137C:12–23PubMedCrossRef Weksberg R, Shuman C, Smith A (2005) Beckwith-Wiedemann syndrome. Am J Med Genet 137C:12–23PubMedCrossRef
69.
Zurück zum Zitat Weksberg R, Shuman C, Beckwith JB (2010) Beckwith–Wiedemann syndrome. Eur J Hum Genet 18:8–14PubMedCrossRef Weksberg R, Shuman C, Beckwith JB (2010) Beckwith–Wiedemann syndrome. Eur J Hum Genet 18:8–14PubMedCrossRef
70.
Zurück zum Zitat Zarate YA, Mena R, Martin LJ et al (2009) Experience with hemihyperplasia and Beckwith–Wiedemann syndrome surveillance protocol. Am J Med Genet 149A:1691–1697PubMedCrossRef Zarate YA, Mena R, Martin LJ et al (2009) Experience with hemihyperplasia and Beckwith–Wiedemann syndrome surveillance protocol. Am J Med Genet 149A:1691–1697PubMedCrossRef
Metadaten
Titel
Educational paper
Screening in cancer predisposition syndromes: guidelines for the general pediatrician
verfasst von
Alexis Teplick
Megan Kowalski
Jaclyn A. Biegel
Kim E. Nichols
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 3/2011
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-010-1377-2

Weitere Artikel der Ausgabe 3/2011

European Journal of Pediatrics 3/2011 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.